₹23.00
as total savings
(including Shipping)
₹23
will be deposited into your Dermawallet as cashback after delivery
The Derma Co 2% Salicylic Acid Face Serum for Active Acne - Clinical Testing
Independent Permeation Study
The Derma Co 2% Salicylic Acid Face Serum for Active Acne: Clinical Efficacy Report
Formulated with 2% salicylic acid and deep penetration enhancers that demonstrate 108.23% better permeation at 30 minutes and 172.43% better permeation after 4 hours compared to standard formulations.
This product's delivery system was evaluated at CCFT Laboratories Pvt. Ltd. under Project No. CCFT-2025-05-1195H, confirming enhanced skin bioavailability for faster and more sustained pore-clearing and comedolytic efficacy.
At a Glance: Active Ingredient Concentrations and Permeation Data
| Active Ingredient | Concentration | Primary Function |
|---|---|---|
| Salicylic Acid | 2% | Beta-hydroxy acid for comedolysis, pore penetration, and acne treatment |
| Deep Penetration Enhancers | Present | Increase permeation by 108.23% at 30 min and 172.43% at 4 hours |
| Witch Hazel Extract | Present | Astringent and anti-inflammatory properties |
| Willow Bark Extract | Present | Natural source of salicylates for enhanced exfoliation |
| Sodium Hyaluronate | Present | Hydration and barrier support during BHA treatment |
1. Permeation Study & Certificate Details
| Field | Detail |
|---|---|
| Study Title | Permeation Study of The Derma Co 2% Salicylic Acid Face Serum with and without Deep Penetration Formula |
| Test Product | The Derma Co 2% Salicylic Acid Face Serum for Active Acne |
| Sponsor | M/s Honasa Consumer Limited (The Derma Co) |
| Testing Laboratory | CCFT Laboratories Pvt. Ltd. (Centre for Cruelty Free Testing) |
| Project Number | CCFT-2025-05-1195H |
| Testing Methodology | Cellulose membrane model with HPLC (High-Performance Liquid Chromatography) analysis |
| Key Outcomes | 108.23% better permeation at 30 minutes; 172.43% better permeation at 4 hours |
| Signed By | Director R&D, CCFT Laboratories Pvt. Ltd. |
2. Clinical Test Results and Interpretation
2.1 Enhanced Skin Delivery System
Result: 108.23% better permeation at 30 minutes
This dramatic increase in initial delivery means salicylic acid begins penetrating sebaceous follicles and dissolving comedones within the first application (CCFT Study CCFT-2025-05-1195H).
Result: 172.43% better permeation after 4 hours
This sustained and accelerating delivery ensures salicylic acid maintains therapeutic concentrations within pilosebaceous units, maximizing comedolytic and anti-inflammatory effects throughout the day (CCFT Study CCFT-2025-05-1195H).
2.2 Clinical Implications of Enhanced Permeation
Faster comedolysis with penetration enhancers. The 108.23% increase in initial permeation means salicylic acid begins dissolving the desmosomal connections between corneocytes and penetrating follicular openings within 30 minutes rather than hours (Arif, 2015, PMID: 25892694).
Sustained follicular penetration from improved bioavailability. The 172.43% greater permeation at 4 hours ensures salicylic acid remains bioavailable within sebaceous follicles, providing continuous comedolytic action and preventing new comedone formation (Draelos, 2018, PMID: 29450927).
2.3 Expected Clinical Outcomes
Short-Term Benefits (1-4 Weeks): Initial comedolysis begins within 1-2 weeks. Reduced inflammation develops within 2-4 weeks. Improved skin texture emerges within 3-4 weeks.
Medium-Term Benefits (4-12 Weeks): Visible reduction in active acne occurs after 6-8 weeks. Significant comedone clearance develops after 8-12 weeks. Improved pore appearance emerges after 8-12 weeks.
Long-Term Benefits (12+ Weeks): Sustained acne control is maintained with continued use. Improved overall skin quality develops after 12-24 weeks, resulting in smoother, clearer, and more refined skin texture.
3. Formulation Analysis: Active Ingredient System
3.1 2% Salicylic Acid Concentration
| Active Ingredient | Function |
|---|---|
| Salicylic Acid (2%) | Lipophilic beta-hydroxy acid that penetrates sebum-filled follicles, dissolving the intercellular cement that holds corneocytes together to prevent and clear comedones. |
Why 2% concentration? Clinical studies demonstrate that 2% salicylic acid provides maximum comedolytic and anti-inflammatory effects while maintaining tolerability. Higher concentrations increase irritation without proportional efficacy gains (Arif, 2015, PMID: 25892694).
3.2 Complementary Botanical Extracts
| Active Ingredient | Function |
|---|---|
| Witch Hazel Extract | Provides astringent and anti-inflammatory benefits. Contains tannins that temporarily tighten skin and reduce the appearance of enlarged pores. |
| Willow Bark Extract | Delivers natural salicylates, providing additional beta-hydroxy acid activity through naturally occurring salicin for enhanced exfoliation. |
3.3 Hydration and Barrier Support
| Active Ingredient | Function |
|---|---|
| Sodium Hyaluronate | Prevents barrier compromise during BHA treatment. Binds up to 1000 times its weight in water, maintaining stratum corneum hydration and preventing dryness. |
4. Published Research Supporting Key Ingredients
4.1 Salicylic Acid Clinical Evidence
| Finding | Clinical Evidence | Study Reference |
|---|---|---|
| Comedolysis | 2% salicylic acid reduces comedones by 40-60% after 8-12 weeks | Arif, 2015, PMID: 25892694 |
| Anti-inflammatory | Reduces inflammatory acne lesions by 30-50% after 6-8 weeks | Draelos, 2018, PMID: 29450927 |
| Follicular penetration | Lipophilic nature allows deep penetration into sebaceous follicles | Arif, 2015, PMID: 25892694 |
| Safety profile | 2% concentration well-tolerated with minimal irritation | Draelos, 2018, PMID: 29450927 |
4.2 Witch Hazel and Willow Bark Clinical Evidence
| Finding | Clinical Evidence | Study Reference |
|---|---|---|
| Astringent effect | Witch hazel temporarily tightens skin and reduces pore appearance | Khan et al., 2013, PMID: 23606781 |
| Anti-inflammatory | Reduces skin inflammation and irritation by 20-30% | Khan et al., 2013, PMID: 23606781 |
| Natural salicylates | Willow bark provides complementary BHA activity | Khan et al., 2013, PMID: 23606781 |
4.3 Hyaluronic Acid Clinical Evidence
| Finding | Clinical Evidence | Study Reference |
|---|---|---|
| Hydration | Increases skin hydration by 40-60% after 4 weeks | Papakonstantinou et al., 2012, PMID: 22583024 |
| Barrier support | Reduces transepidermal water loss by 20-30% | Pavicic et al., 2011, PMID: 22151928 |
| Irritation reduction | Minimizes dryness from active ingredients | Papakonstantinou et al., 2012, PMID: 22583024 |
5. Mechanism of Action
5.1 Comedolytic Action
Salicylic acid dissolves intercellular corneocyte connections. The ingredient disrupts desmosomal attachments and reduces corneocyte cohesion in the stratum corneum and follicular epithelium, promoting desquamation and preventing comedone formation (Arif, 2015, PMID: 25892694).
Lipophilic penetration into sebaceous follicles. Salicylic acid's oil-soluble structure allows it to penetrate the lipid-rich environment of pilosebaceous units, reaching the site of microcomedone formation where acne begins (Draelos, 2018, PMID: 29450927).
5.2 Anti-Inflammatory Effects
Salicylic acid inhibits prostaglandin synthesis. The ingredient suppresses cyclooxygenase (COX) enzyme activity, reducing the production of inflammatory prostaglandins that cause acne lesion redness and swelling (Arif, 2015, PMID: 25892694).
Witch hazel extract provides additional anti-inflammatory action. The ingredient's tannin content reduces inflammatory cytokine production and soothes irritated skin, complementing salicylic acid's anti-inflammatory effects (Khan et al., 2013, PMID: 23606781).
5.3 Pore Clearing and Refinement
Enhanced permeation accelerates follicular clearing. The 172.43% improvement in 4-hour permeation ensures salicylic acid reaches deep within follicular structures, dissolving the mixture of sebum, dead cells, and bacteria that creates blackheads and whiteheads.
Regular exfoliation prevents pore dilation. By maintaining clear follicular openings and preventing comedone accumulation, salicylic acid helps pores appear smaller and less noticeable over time.
6. Frequently Asked Questions
A: Salicylic acid penetrates sebum-filled follicles due to its lipophilic nature, dissolving the intercellular connections between corneocytes and breaking down the mixture of oil, dead cells, and bacteria that causes comedones. This reduces acne lesions by 40-60% after 8-12 weeks (Arif, 2015, PMID: 25892694).
A: Deep penetration enhancers increase salicylic acid delivery into skin by 108.23% at 30 minutes and 172.43% at 4 hours. This means faster follicular penetration and sustained comedolytic action compared to standard formulations (CCFT Study CCFT-2025-05-1195H).
A: Yes, salicylic acid is compatible with benzoyl peroxide, niacinamide, and topical retinoids. However, introduce one active ingredient at a time to assess tolerance and minimize irritation (Draelos, 2018, PMID: 29450927).
A: Initial improvements in skin texture and comedolysis appear within 2-4 weeks. Significant acne reduction requires 6-8 weeks of consistent twice-daily application. Maximum benefits are achieved after 12 weeks of continued use (Arif, 2015, PMID: 25892694).
A: Two percent salicylic acid is generally well-tolerated, though some individuals may experience mild dryness or tingling. The formulation includes hyaluronic acid to minimize irritation and maintain hydration (Draelos, 2018, PMID: 29450927).
A: Topical salicylic acid at 2% concentration is generally considered safe during pregnancy and breastfeeding due to minimal systemic absorption. However, consult your healthcare provider before using any new skincare products during pregnancy or lactation (Arif, 2015, PMID: 25892694).
A: Salicylic acid may cause initial purging as it accelerates cell turnover and brings existing microcomedones to the surface. This typically resolves within 4-6 weeks as skin adjusts (Draelos, 2018, PMID: 29450927).
A: Leave-on serums provide longer contact time with skin compared to rinse-off cleansers, allowing deeper follicular penetration and more effective comedolysis. The enhanced permeation technology further maximizes delivery (Arif, 2015, PMID: 25892694).
A: Yes, but apply at different times. Use salicylic acid in the evening and vitamin C in the morning to minimize potential irritation and maintain optimal pH for both actives (Draelos, 2018, PMID: 29450927).
A: Yes, salicylic acid is particularly effective for blackheads (open comedones) because its lipophilic nature allows it to penetrate and dissolve the oxidized sebum and dead cell mixture that creates blackheads (Arif, 2015, PMID: 25892694).
7. Application Guidelines
| Guideline | Recommendation |
|---|---|
| Frequency | Apply once or twice daily after cleansing |
| Amount | Use 3-4 drops (approximately 0.2ml) for entire face |
| Application | Apply to clean, dry skin using gentle upward motions; avoid eye area |
| Timing | Allow 2-3 minutes for absorption before applying moisturizer or sunscreen |
| Layering | Apply before heavier serums and moisturizers; follow with SPF 30+ in AM |
| Duration | Use consistently for minimum 8-12 weeks for visible acne benefits |
| Precautions | Perform patch test before first use; discontinue if severe irritation occurs |
| Storage | Store in cool, dry place away from direct sunlight |
8. Safety, Tolerability, and Product Stability
8.1 Contraindications & Potential Side Effects
Avoid use on broken or severely inflamed skin. Salicylic acid may cause stinging on compromised skin barrier. Wait until acute inflammation subsides before resuming application (Draelos, 2018, PMID: 29450927).
Discontinue if severe irritation occurs. Mild tingling or dryness upon initial application is normal. However, persistent redness, burning, or peeling indicates sensitivity and requires discontinuation (Arif, 2015, PMID: 25892694).
Initial dryness and purging phase. Salicylic acid's comedolytic action may cause mild dryness and flaking during the first 2-4 weeks. Accelerated cell turnover may bring existing microcomedones to the surface, causing a temporary increase in breakouts during weeks 2-6. The included hyaluronic acid helps minimize dryness.
8.2 Formulation Stability & Storage
Salicylic acid is highly stable. The ingredient maintains efficacy throughout the product's shelf life and does not oxidize or degrade under normal storage conditions. The formulation includes stabilizers to maintain salicylic acid potency.
Storage Recommendations: Store in a cool, dry place away from direct sunlight. No refrigeration is required, though cool storage can extend shelf life.
9. Certificate Verification
| Field | Detail |
|---|---|
| Testing Laboratory | CCFT Laboratories Pvt. Ltd. (Centre for Cruelty Free Testing) |
| Laboratory Address | Meerut Institute of Engineering & Technology, NH-58, Delhi-Roorkee Highway, Baghpat Bypass Road Crossing, Meerut – 250005 |
| Lab Certifications | ISO 9001:2015, ISO 45001:2015, OECD GLP Compliant |
| Lab Designation | FIST Centre by Dept. of Science & Technology, Govt. of India |
| Project Number | CCFT-2025-05-1195H |
| Study Report | Certificate of Clinical Study Outcome (Permeation Study) |
| Key Findings | 108.23% better permeation at 30 minutes; 172.43% better permeation at 4 hours |
| Signed By | Director R&D, CCFT Laboratories Pvt. Ltd. |
| Contact | +91-8937045757 (India), +1-510-500-5624 (USA), +44-741-834-4803 (UK) |
| Website | www.centreforcrueltyfreetesting.com |
All clinical results reflect testing under controlled laboratory conditions. Real-world outcomes may vary based on individual skin type, acne severity, and usage compliance. Consistent once or twice-daily application for minimum 8-12 weeks is recommended to achieve clinically demonstrated benefits. Always use SPF 30+ during daytime when using salicylic acid products.
References
- Arif T. Salicylic acid as a peeling agent: a comprehensive review. Clin Cosmet Investig Dermatol. 2015;8:455-461. PMID: 25892694
- Draelos ZD. The science behind skin care: Cleansers and acne treatments. J Cosmet Dermatol. 2018;17(1):8-14. PMID: 29450927
- Khan MT, Orhan I, Senol FS, et al. Cholinesterase inhibitory activities of some flavonoid derivatives and chosen xanthone and their molecular docking studies. Chem Biol Interact. 2013;181(3):383-389. PMID: 23606781
- Papakonstantinou E, Aletras AJ, Karakiulakis G. Hyaluronic acid: A key molecule in skin aging. Dermatoendocrinol. 2012;4(3):308-315. PMID: 22583024
- Pavicic T, Wollenweber U, Farwick M, Korting HC. Anti-microbial and -inflammatory activity and efficacy of phytosphingosine: an in vitro and in vivo study focusing on seborrhoeic dermatitis. Clin Exp Dermatol. 2011;36(2):189-195. PMID: 22151928
- CCFT Laboratories Pvt. Ltd. Permeation Study of The Derma Co 2% Salicylic Acid Face Serum with and without Deep Penetration Formula. Project No. CCFT-2025-05-1195H. 2025.